siRNA, Anti-ATG2A, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT36708WQ-2OMe)

The product SIRGT36708WQ-2OMe is a type of small interfering RNA (siRNA) that targets ATG2A gene and regulates the expression of gene. The siRNA interferes with the expression of ATG2A gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_015104.2
Related Diseases Spinocerebellar ataxia
Purification HPLC
Target Gene
Gene ID 23130
Uniprot ID Q2TAZ0
Sub Cat Target Species Modification Scale  
SIRGT37708WQ-2F ATG2A Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT38708WQ-2MOE ATG2A Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT39708WQ-LNA ATG2A Human Locked Nucleic Acid (LNA) Inquiry
SIRGT36708WQ-RB ATG2A Human Ribo-modified Inquiry
SIRGT37708WQ-BB ATG2A Human Backbone-modified Inquiry

Related Products